stock

Incyte Corp. (INCY)

0

Share

Stay up to date

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.

Financial Statements

Key Info

  • Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
  • Sector: Professional, Scientific, and Technical Services
  • CEO Name:

Key Statistics

  • Stock Price: $84.13
  • Dividend Yield: 0%
  • Market Capitalization: $18,627,518,502
  • Shares Outstanding: 219,923,477
  • Number of Employees: 0
  • Trailing 12-Month EPS: $2.18
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date: 2021-08-03
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $84.13
  • 52-week high: $110.37
  • 52-week low: $75.52
  • 200-day moving average: $84.62
  • 50-day moving average: $83.74

Performance

  • 1-Month Price Return: 1.1%
  • 3-Month Price Return: 4.4%
  • 6-Month Price Return: -1.4%
  • 1-Year Price Return: -17.3%
  • 2-Year Price Return: -0.3%
  • 5-Year Price Return: 7.6%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast